Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
67.81 USD | -1.02% | -4.84% | -12.80% |
Strengths
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Analyst opinion has improved significantly over the past four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- The group shows a rather high level of debt in proportion to its EBITDA.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-12.80% | 6.36B | C+ | ||
+25.91% | 88.08B | C+ | ||
-24.02% | 75.32B | B- | ||
+3.45% | 28.19B | C+ | ||
+7.05% | 17.78B | A- | ||
-13.61% | 16.64B | B | ||
+0.69% | 15.64B | A- | ||
+79.76% | 13.81B | C- | ||
-26.67% | 13.01B | - | - | |
+22.83% | 12.43B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- ACHC Stock
- Ratings Acadia Healthcare Company, Inc.